![Jeremy Bender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeremy Bender
Direktor/Vorstandsmitglied bei
MEREO BIOPHARMA GROUP PLC
Vermögen: 218 751 $ am 31.08.2026
Profil
Jeremy Bender is currently Chief Executive Officer at DOT Therapeutics-2, Inc. Dr. Bender is an Independent Director at Mereo BioPharma Group Plc since 2020.
Dr. Bender is an Independent Director at Aura Biosciences, Inc. starting in 2026.
Dr. Bender is an Independent Director at Bicara Therapeutics, Inc. starting in 2026.
Formerly, Dr. Bender was President, CEO & Non-Independent Director at Day One Biopharmaceuticals, Inc. from 2020 to 2026.
Dr. Bender was Director at Fusion Pharmaceuticals, Inc. from 2023 to 2024.
Dr. Bender was Vice President-Corporate Development at Gilead Sciences, Inc. from 2018 to 2020.
Dr. Bender was Vice President-Corporate Development at Allos Therapeutics, Inc. from 2006 to 2012.
Dr. Bender was Chief Business Officer at Sutro Biopharma, Inc. from 2012 to 2015.
Dr. Bender was Project Leader at The Boston Consulting Group, Inc. Dr. Bender was Chief Operating Officer at Tizona Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate degree from Stanford University, doctorate from The University of Colorado, and MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,03 % | 07.07.2026 | 30.000 ( 0,03 % ) | 215 400 $ | 31.08.2026 |
| 26.03.2026 | 62.750 ( 0,01 % ) | 3 351 $ | 31.08.2026 |
Aktive Positionen von Jeremy Bender
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Direktor/Vorstandsmitglied | 01.10.2020 |
| AURA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 07.07.2026 |
| BICARA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 28.07.2026 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jeremy Bender
| Unternehmen | Position | Ende |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Vorstandsvorsitzender | 23.04.2026 |
| FUSN PHAR | Direktor/Vorstandsmitglied | 04.06.2024 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.09.2020 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Geschäftsführer | 01.03.2018 |
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Jeremy Bender
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
